Related Experiment Videos

Meltrin beta mini, a new ADAM19 isoform lacking metalloprotease and disintegrin domains, induces morphological

Tomohiro Kurisaki1, Shuji Wakatsuki, Atsuko Sehara-Fujisawa

  • 1Department of Growth Regulation, Institute for Frontier Medical Sciences, Kyoto University, 606-8507, Kyoto, Japan.

FEBS Letters
|December 17, 2002
PubMed

Insights

A novel meltrin beta mini isoform promotes neurite outgrowth in neuronal cells, suggesting a unique role in neurogenesis distinct from the full-length meltrin beta (ADAM19).

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Meltrin beta (ADAM19) is a metalloprotease-disintegrin crucial during embryogenesis.
  • It is expressed in the peripheral nervous system and various organs.

Purpose of the Study:

  • To identify and characterize alternatively spliced isoforms of meltrin beta.
  • To investigate the functional role of a novel isoform in neuronal development.

Main Methods:

  • RT-PCR was used to detect the meltrin beta mini isoform in murine dorsal root ganglion and neuronal cell lines.
  • cDNA and genomic sequences were compared to identify novel exons.
  • Neuronal cells were transfected to study the effects of meltrin beta mini overexpression.

Main Results:

  • An alternatively spliced isoform, meltrin beta mini, lacking key domains (prodomain, metalloprotease, disintegrin) was identified.
  • This novel isoform was detected in specific neuronal tissues and cell lines.
  • Overexpression of meltrin beta mini, but not full-length meltrin beta, significantly induced neurite outgrowth.

Conclusions:

  • The meltrin beta mini isoform represents a distinct functional variant of ADAM19.
  • This isoform plays a specific role in promoting neurogenesis, particularly neurite outgrowth.
  • Further research into meltrin beta mini could reveal new therapeutic targets for neurological disorders.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...